Small molecule-switchable RNA platform enables control of therapeutic protein expression

Just like a doctor adjusts the dose of a medication to the patient's needs, the expression of therapeutic genes, those modified in a person to treat or cure a disease via gene therapy, also needs to be maintained within a therapeutic window.

Related Keywords

Yan Wang ,Jocelyn Duen Ya Jea ,Pei Wen Chao ,Department Of Pathology ,Doctoral Fellowship For Biomedical Research ,Baylor College Of Medicine ,Em Foundation Pre ,Drug Administration ,Nature Biotechnology ,Baylor College ,Laising Yen ,Biomedical Research ,Facility Support Award ,Gene ,Gene Therapy ,Genes ,Biotechnology ,Doctor ,Wood ,Ene Expression ,Immune Response ,Mmunology ,Mammalian Cells ,Medicine ,Olecule ,Pathology ,Protein ,Research ,Na ,Small Molecules ,Technology ,Tetracycline ,